Recombinant live avian vaccine, using as vector the avian infectious laryngotracheitis virus
US6033670A · kind A · utility
16Cited by
1References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 29, 1997 |
| Grant date | Mar 7, 2000 |
| Priority date | — |
| Expiry date | Jan 29, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2840/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The recombinant live avian vaccine comprises as vector an ILTV virus comprising and expressing at least one heterologous nucleotide sequence, this nucleotide sequence being inserted into the insertion locus formed by the intergenic region located between the stop codons of ORF B and ORF C of ILTV, which region, in a particular strain of ILTV, is defined between nucleotides 908 and 994 in SEQ ID NO:1.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.